Verapamil and beta cell function in adults with recent-onset type 1 diabetes
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Verapamil and beta cell function in adults with recent-onset type 1 diabetes
Authors
Keywords
-
Journal
NATURE MEDICINE
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-07-06
DOI
10.1038/s41591-018-0089-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Verapamil Use Is Associated With Reduction of Newly Diagnosed Diabetes Mellitus
- (2017) Ti Yin et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Fall in C-Peptide During First 4 Years From Diagnosis of Type 1 Diabetes: Variable Relation to Age, HbA 1c , and Insulin Dose
- (2016) Wei Hao et al. DIABETES CARE
- Calcium channel blocker use is associated with lower fasting serum glucose among adults with diabetes from the REGARDS study
- (2016) Yulia Khodneva et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Multiple Imputation
- (2015) Peng Li et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Combination immunotherapies for type 1 diabetes mellitus
- (2015) Paolo Pozzilli et al. Nature Reviews Endocrinology
- Low-Dose Otelixizumab Anti-CD3 Monoclonal Antibody DEFEND-1 Study: Results of the Randomized Phase III Study in Recent-Onset Human Type 1 Diabetes
- (2014) Ronnie Aronson et al. DIABETES CARE
- Prevalence of Detectable C-Peptide According to Age at Diagnosis and Duration of Type 1 Diabetes
- (2014) Asa K. Davis et al. DIABETES CARE
- Preventing -Cell Loss and Diabetes With Calcium Channel Blockers
- (2012) G. Xu et al. DIABETES
- Fall in C-Peptide During First 2 Years From Diagnosis: Evidence of at Least Two Distinct Phases From Composite Type 1 Diabetes TrialNet Data
- (2012) C. J. Greenbaum et al. DIABETES
- Recommendations for Planning Pilot Studies in Clinical and Translational Research
- (2011) Charity G. Moore et al. CTS-Clinical and Translational Science
- Sample Size Requirements for Studies of Treatment Effects on Beta-Cell Function in Newly Diagnosed Type 1 Diabetes
- (2011) John M. Lachin et al. PLoS One
- Diabetes induces and calcium channel blockers prevent cardiac expression of proapoptotic thioredoxin-interacting protein
- (2009) Junqin Chen et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Pancreatic beta cell function persists in many patients with chronic type 1 diabetes, but is not dramatically improved by prolonged immunosuppression and euglycaemia from a beta cell allograft
- (2009) E. H. Liu et al. DIABETOLOGIA
- Thioredoxin-interacting protein links oxidative stress to inflammasome activation
- (2009) Rongbin Zhou et al. NATURE IMMUNOLOGY
- Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function
- (2009) Mark D. Pescovitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Thioredoxin-Interacting Protein: A Critical Link Between Glucose Toxicity and -Cell Apoptosis
- (2008) J. Chen et al. DIABETES
- Mixed-Meal Tolerance Test Versus Glucagon Stimulation Test for the Assessment of -Cell Function in Therapeutic Trials in Type 1 Diabetes
- (2008) C. J. Greenbaum et al. DIABETES CARE
- Thioredoxin-interacting protein deficiency induces Akt/Bcl-xL signaling and pancreatic beta-cell mass and protects against diabetes
- (2008) Junqin Chen et al. FASEB JOURNAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now